SOLITHROMYCIN VERSUS FLUOROQUINOLONES FOR PNEUMONIA CAUSED BY ATYPICAL BACTERIA: A META-ANALYSIS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-029
- By: ELJAALY, Khalid (King Abdulaziz University, Pharmacy Practice, Saudi Arabia)
- Co-author(s): Khalid Eljaaly: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
Samah Alshehri: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
BackgroundThe clinical practice guidelines recommend empiric coverage of atypical bacteria in patients with community-acquired pneumonia (CAP). Solithromycin is a novel ketolide antibiotic which has not been yet approved for CAP.
MethodsTwo researchers independently searched the PubMed, EMBASE and Cochrane Library databases for relevant.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 28 September 2023